T1	TimeFrame 32 107	at 28 days after randomisation, with further analyses specified at 6 months
T2	PrimaryOutcome 140 159	all-cause mortality
T3	SecondaryOutcome 185 216	time to discharge from hospital
T4	SecondaryOutcome 294 404	post-enrolment use of invasive mechanical ventilation (including extracorporeal membrane oxygenation) or death
T5	OtherOutcome 453 477	cause-specific mortality
T6	OtherOutcome 520 544	major cardiac arrhythmia
T7	OtherOutcome 479 518	use of haemodialysis or haemofiltration
T8	OtherOutcome 703 738	suspected serious adverse reactions
T9	OtherOutcome 573 608	receipt and duration of ventilation
R1	MeasuredAt Arg1:T3 Arg2:T1	
R2	MeasuredAt Arg1:T4 Arg2:T1	
R3	MeasuredAt Arg1:T2 Arg2:T10	
R4	MeasuredAt Arg1:T5 Arg2:T1	
R5	MeasuredAt Arg1:T7 Arg2:T1	
R6	MeasuredAt Arg1:T6 Arg2:T1	
R7	MeasuredAt Arg1:T9 Arg2:T1	
R8	MeasuredAt Arg1:T8 Arg2:T1	
T10	TimeFrame 133 139	28-day
